Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS

ConclusionsThe high concordance between the different DNA sources forEGFR mutation testing supports the use of plasma samples when tumor tissue is unavailable.

Source: Clinical and Translational Oncology - October 1, 2018 Category: Cancer & Oncology Source Type: research